China's Medtech Regulatory Update Does Not Go Far Enough For Overseas Innovators
Law firm claims playing field is still far from level
Executive Summary
Foreign medical device innovators accessing the Chinese market remain at a disadvantage to local companies, even after the recent regulatory pathway revision.
You may also be interested in...
Spinning To Be Agile: GE Healthcare’s Precision Health Ambition Majors On Lean
Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.
Spinning To Be Agile: GE Healthcare’s Precision Health Ambition Majors On Lean
Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.
Chinese Medtech Contracting And Liability Changes From 1 June
China has amended its 2014 primary regulation governing medical devices. The new version of the Regulation on Supervision and Administration of Medical Devices comes into force on 1 June, says Todd Liao of Morgan Lewis.